RNA5SP94

Across TCGA pan-cancer cohorts, RNA5SP94 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated RNA5SP94 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNA5SP94 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNA5SP94 expression acts as an unfavorable survival marker.

STAD, KIRC, and SKCM are the cancer types where RNA5SP94 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.357	0.670	<.001	90	view →
KIRC	OS	Tertile	II,III,IV	0.221	0.791	<.001	90	view →
SKCM	DFS	Tertile	All	0.016	0.758	<.001	72	view →
THCA	DFS	Tertile	All	0.049	0.828	<.001	54	view →
ESCA	DFS	Tertile	II,III,IV	0.272	0.529	.043	9	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RNA5SP94–STAD (DFS)

Open the STAD breakdown →